The Cardiovascular Risk Factor Your Doctor Never Tested For: MTHFR, Homocysteine, and Heart Disease

Cardiovascular disease remains the leading cause of death in Ireland, the UK, and across Europe. Most prevention efforts focus on cholesterol, blood pressure, smoking, and weight. But there is a risk factor that is independently associated with heart attack, stroke, and coronary artery disease — one that affects up to 40% of the Irish population — that your doctor has probably never tested for.

That risk factor is elevated homocysteine, driven by the MTHFR gene variant. And unlike cholesterol — which requires dietary change, statins, and years of management — homocysteine elevation is one of the most straightforward and responsive cardiovascular risk factors to address.

How Homocysteine Damages the Cardiovascular System

Homocysteine is directly toxic to the vascular endothelium — the thin layer of cells lining every blood vessel in your body. At elevated levels, it induces oxidative stress in endothelial cells, promotes inflammation in vessel walls, disrupts nitric oxide production (the primary vasodilator that keeps arteries flexible), stimulates smooth muscle proliferation that narrows arteries, activates platelet aggregation increasing clotting risk, and promotes the oxidation of LDL cholesterol — a key step in atherosclerotic plaque formation.

The result is accelerated atherosclerosis — hardening and narrowing of the arteries — that increases the risk of coronary artery disease, heart attack, and stroke independently of every other cardiovascular risk factor. Independently — meaning even if your cholesterol is normal, your blood pressure is controlled, and you don't smoke, elevated homocysteine still elevates your cardiovascular risk.

The Research Is Unambiguous

The Homocysteine Studies Collaboration — a meta-analysis of over 30 prospective studies involving more than 5,000 cardiovascular events — found that a 25% lower homocysteine level was associated with an 11% lower risk of coronary heart disease and a 19% lower risk of stroke. These associations were independent of all other cardiovascular risk factors. The evidence is substantial enough that elevated homocysteine is now recognised as an independent cardiovascular risk factor by major cardiology bodies worldwide.

A separate Mendelian randomisation analysis — using genetic variants to establish causation rather than mere association — confirmed that the relationship between homocysteine and cardiovascular disease is causal, not just correlational. Your homocysteine level is not just a marker of risk. It is a mechanism of harm.

MTHFR and Cardiovascular Risk

The MTHFR C677T variant is the most common genetic cause of elevated homocysteine in the general population. Homozygous C677T — having two copies of the variant, which affects approximately 10–15% of people of European descent — is associated with homocysteine levels approximately 25% higher than those without the variant, with further elevation under conditions of low folate intake. This translates directly into elevated cardiovascular risk that is both measurable and modifiable.

For people with a family history of early cardiovascular disease — a heart attack before 60, a stroke in a parent or sibling — MTHFR testing and homocysteine measurement should be among the first investigations. They rarely are.

What to Do

Getting your homocysteine level tested is a straightforward first step. A normal level is below 10 µmol/L. Anything above 12 warrants targeted nutritional intervention. If your level is elevated, addressing it through methylfolate, methylcobalamin B12, and P5P B6 — in their active, bioavailable forms — is the most evidence-based approach. The Homocysteine Lowering Trialists' Collaboration found that B vitamin supplementation reduces homocysteine by an average of 25% — directly translating into reduced cardiovascular risk.

→ What is homocysteine? Complete guide
→ Read: MTHFR, Homocysteine, and Stroke
→ Read: High Blood Pressure and Homocysteine

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. If you have cardiovascular disease or significant risk factors, please work with your GP or cardiologist.